Skip to main content
    N

    Nakamoto Inc. (NAKA)

    Official site

    FINANCIAL SERVICES • MEDICAL CARE FACILITIES • NASDAQ

    $8.09
    +0.13 (+1.63%)

    Market Cap: $142.44M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(2/4)
    Avg Surprise
    -1715.56%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.48
    Range$-0.49 - $-0.48
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.41-16.9%
    60d ago$-0.41-16.9%
    30d ago$-0.45-7.8%
    7d ago$-0.480.0%
    Current$-0.48
    Revenue Consensus
    $17M
    Range$15M - $20M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-19.96
    Range$-19.96 - $-19.96
    1 analysts
    Revenue Consensus
    $39M
    Range$32M - $45M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-19.96---
    Sep 26EST
    		-$-0.48---
    Jun 26
    Reported Aug 13
    		$1.13$-0.61+285.25%Beat+422.9%
    Mar 26
    Reported May 13
    		$-15.20$-0.20-7500.00%Miss-8841.2%
    Dec 25
    Reported Mar 30
    		$0.07$-0.01+800.00%Beat+141.2%
    Sep 25
    Reported Nov 19
    		$-2.19$-0.40-447.50%Miss+67.7%
    Jun 25
    Reported Aug 5
    		$-0.35N/AN/ABeat+96.1%
    Mar 25
    Reported May 8
    		$-0.17N/AN/ABeat-
    Dec 24
    Reported Mar 28
    		$-0.17N/AN/ABeat-
    Sep 24
    Reported Nov 12
    		$-6.79N/AN/ABeat-
    Jun 24
    Reported Aug 13
    		$-8.89N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.50EV/EBITDAN/A
    Price/FCF-2.28xFCF Yield-43.92%
    Profitability
    Profit Margin0.00%Operating Margin-25.10%
    ROE-343.30%ROIC-100.77%
    Financial Health
    Debt/Equity0.70xInterest CoverageN/A
    Current Ratio0.15xQuick Ratio0.15x
    Trading Statistics
    Beta15.70Avg Volume215.36K
    52-Week High$42.0052-Week Low$3.33

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$8.90
    SMA 20$9.25
    SMA 50$7.78
    SMA 200$8.56
    EMA 10$8.66
    EMA 20$8.75
    EMA 50$7.98
    EMA 200$27.28

    MACD

    Line: 0.09Signal: 0.38Hist: -0.29

    ADX

    ADX: 30.1+DI: 15.6-DI: 23.3

    Aroon & PSAR

    Aroon Up68.0
    Aroon DownN/A
    PSAR$9.77

    Bollinger Bands

    Upper Band$10.58
    Lower Band$7.93
    %B Position2866%(Upper)
    Band Width0.06

    RSI (14-Day)

    Neutral
    44.4

    Momentum Oscillators

    Stoch %K12.4
    Stoch %D10.0
    Williams %R-83.5
    ROC (10d)-11.2%
    Momentum-1.02
    CCI (20d)-168.0
    MFI (14d)38.5

    Volatility Measures

    ATR (14d)$0.67(8.3%)
    StdDev (20d)0.66
    Hist Vol79.6%(High)

    Volume Flow

    VWAP$7.96
    OBV-432.1M
    AD Line1786.4B
    CMF (20d)-0.096

    Volume Metrics

    Avg Vol (20d)214.8K
    Vol Ratio0.5x
    VWMA (20d)$9.40

    Pivot Points

    R3$8.84
    R2$8.64
    R1$8.30
    Pivot Point$8.10
    S1$7.76
    S2$7.56
    S3$7.22

    Advanced Oscillators

    TSI4.28
    Ultimate Osc33.5
    KST204.13

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$35.87M$2.68M$444,924$388,209$408,527$580,000$603,887$647,867$639,057$829,029$759,447$869,268
    Cost of Revenue$15.13M$7.58M$11.07M$2,015$7,552$1.01M$663,213$1.20M$1.24M$765,870$866,476$1.03M
    Gross Profit$20.74M$-4,901,000$-10,625,650$386,194$400,975$-431,000$-59,326$-547,757$-601,786$63,159$-107,029$-159,036
    Operating Expenses$169.82M$121.27M$172.67M$10.79M$2.79M$611,000$963,307$502,061$435,407$300,286$195,100$344,367
    R&D$0$0$101$0$4$97$377,731$0$342,314$35,417$2,500$0
    SG&A$14.29M$9.78M$3.39M$10.78M$2.78M$593,000$1.18M$1.66M$1.59M$1.03M$195,100$357,369
    Operating Income$-149,079,000$-126,170,000$-183,300,488$-10,405,522$-2,391,491$-1,042,000$-1,022,632$-1,049,818$-1,037,193$-237,127$-302,129$-503,403
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$4.02M$4.22M$7.05M$0$3,668$6,000$8,100$9,659$318,450$57,239$55,844$12,550
    Income Before Tax$-152,623,000$-238,776,000$37.26M$-86,035,808$-2,413,787$-1,038,000$-1,001,521$-1,014,146$-1,319,653$-282,326$-324,928$-515,146
    Income Tax Expense$-21,424,000$0$0$0$0$0$0$0$0$0$2$-4
    Net Income$-132,997,000$-238,776,000$37.26M$-86,035,808$-2,413,787$-1,038,000$-1,001,521$-1,014,146$-1,319,653$-282,326$-324,928$-515,146
    EBITDA$-146,193,000$-233,441,000$44.38M$-85,370,518$-2,299,427$-1,014,000$-953,737$-1,000,545$-985,190$-186,967$-228,991$-477,399
    EBIT$-148,607,000$-234,556,000$44.31M$-86,035,808$-2,410,119$-1,032,000$-1,022,632$-1,049,818$-1,037,193$-237,127$-302,129$-503,403
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NAKA

    News

    Form PRE 14A Nakamoto Inc. For: Oct 14

    Nakamoto Inc. has filed a preliminary proxy statement (PRE 14A) for its annual meeting of stockholders to be held on December 17, 2026. Key proposals include declassifying the Board of Directors...

    StreetInsider•10/14/26•Somewhat-Bullish

    Form 4 Nakamoto Inc For: 8 October By Investing.com

    This article reports on a Form 4 filing by Nakamoto Inc. for activity on October 8th. The company's stock, NAKA, saw a 3.87% increase, and the article provides financial market data and other related news.

    Investing.com South Africa•10/8/26•Neutral

    Form 4 Nakamoto Inc For: 8 October By Investing.com

    This article reports on a Form 4 filing for Nakamoto Inc. on October 8, 2026. Form 4 filings are used to declare changes in beneficial ownership of securities by company insiders. The article provides the company name...

    Investing.com Canada•10/8/26•Bearish

    Nakamoto Inc. Corrects Dalton Merritt's 42,492-Share Acquisition Reporting Error

    Nakamoto Inc. has corrected an error in a previous filing for its Chief Accounting Officer, John Dalton Merritt. An August 27, 2026...

    Kalkine Media•10/8/26•Neutral

    Form 4 Nakamoto Inc For: 8 October By Investing.com

    This article reports on a Form 4 filing for Nakamoto Inc. on October 8. It provides financial market data, including various indices, commodities, and stock prices...

    Investing.com Canada•10/8/26•Neutral

    NAKA Valuation and Fair Value

    P/E
    -0.5x
    P/FCF
    -2.3x
    P/B
    0.7x
    See GNG's fair value

    NAKA Profitability: Margins, ROIC and FCF

    Gross margin
    14.2%
    Operating margin
    -25.1%
    Net margin
    0.0%
    ROIC
    -100.8%
    ROE
    -343.3%
    FCF margin
    -180.4%
    FCF yield
    -43.9%

    NAKA Competitors

    CompanyTicker
    Repro Med Systems IncKRMD
    Codexis IncCDXS
    Cardiol Therapeutics Inc Class ACRDL
    Molecular Partners AG ADRMOLN
    Neuronetics IncSTIM
    Atrium Therapeutics, Inc. Common StockRNA
    Quanterix CorpQTRX
    Anavex Life Sciences CorpAVXL

    Sector: Healthcare

    NAKA Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    2
    Hold
    0
    Sell
    0
    Strong Sell
    0

    NAKA Bull Case vs Bear Case

    Bull case

    • NAKA grew quarterly revenue 8680.0% year over year.

    NAKA Earnings: Beat Rate and Next Report

    Beat rate
    2 of 4 quarters (50.0%)
    Average surprise
    -1715.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.48
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 2 down

    Frequently Asked Questions About NAKA

    Does NAKA pay dividends?

    Nakamoto Inc. (NAKA) does not currently pay a regular dividend.

    What is NAKA's market cap?

    Nakamoto Inc. (NAKA) has a market capitalization of $142.44M with a current stock price of $8.09.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In